I’m pleased to pass along that my colleagues and I at the Ethics and Public Policy Center have filed an amicus brief in support of the state of Louisiana in response to the emergency applications filed by mifepristone manufacturers. Our brief highlights the study by other EPPC scholars that demonstrates that mifepristone-induced abortion presents severe health risks that are more than 22 times higher than the FDA has acknowledged and that the FD…